Rigel Pharma (RIGL) Tops Q4 EPS by 80c

Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.80. Revenue for the quarter came in at $57.6 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• CNH Industrial Capital prices $600 million in notes due 2031
• FTI Consulting names Jerome Nyssen senior managing director in Australia